Vascular endothelial growth factor inhibitors equally effective for AMD (Macular Degeneration)

MedPage Today (2/1, Bankhead) reported that “visual acuity showed similar improvements with two vascular endothelial growth factor inhibitors used to treat age-related macular degeneration (AMD),” according to a study published in the February issue of the Journal Ophthalmology. In a “study population comprised 324 patients treated with bevacizumab and 128 treated with ranibizumab,” approximately a quarter “of patients treated with bevacizumab” or “ranibizumab…had =20/40 vision at 12 months.” While “the frequency of adverse events did not differ between treatment groups,” the “bevacizumab patients received fewer injections over the course of a year.”

For more information on eye and vision care issues visit


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: